Literature DB >> 6886624

Identification of an active disaccharide unit of a glycoconjugate receptor for pneumococci attaching to human pharyngeal epithelial cells.

B Andersson, J Dahmén, T Frejd, H Leffler, G Magnusson, G Noori, C S Edén.   

Abstract

Glycoconjugates containing the disaccharide unit GlcNAc beta 1 leads to 3Gal beta were suggested as receptors for pneumococci adhering to human pharyngeal epithelial cells. The receptor activity was detected both by inhibition of adhesion by an excess of free oligosaccharide and by induction or increase of adhesion after coating of target cells with glycolipid. Studies with free natural and synthetic oligosaccharides identified the disaccharide GlcNAc beta 1 leads to 3Gal beta as one critical binding site. The specificity of recognition was shown inter alia by the lack of inhibitory activity of GlcNAc beta 1 leads to 4Gal beta, which differs only in the linkage of the two sugars. Specific interference with pneumococcal adhesion by administration of soluble receptor sugar may improve our understanding of the role of adhesion in vivo.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6886624      PMCID: PMC2187347          DOI: 10.1084/jem.158.2.559

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  The sphingolipid composition of bovine kidney cortex, medulla and papilla.

Authors:  K A Karlsson; B E Samuelsson; G O Steen
Journal:  Biochim Biophys Acta       Date:  1973-09-25

2.  Chemical structure of glycolipid of guinea pig red blood cell membrane.

Authors:  Y Seyama; T Yamakawa
Journal:  J Biochem       Date:  1974-04       Impact factor: 3.387

3.  Methylation analysis of the carbohydrate portion of fibronectin isolated from human plasma.

Authors:  M Wrann
Journal:  Biochem Biophys Res Commun       Date:  1978-09-14       Impact factor: 3.575

4.  Pneumonia and pneumococcal infections, with special reference to pneumococcal pneumonia. The 1979 J. Burns Amberson lecture.

Authors:  M Finland
Journal:  Am Rev Respir Dis       Date:  1979-09

5.  An epidemiologic approach to pneumococcal disease.

Authors:  I D Riley; R M Douglas
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr

6.  Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions.

Authors:  M Vuento; A Vaheri
Journal:  Biochem J       Date:  1979-11-01       Impact factor: 3.857

7.  Adherence of group A streptococci to fibronectin on oral epithelial cells.

Authors:  W A Simpson; E H Beachey
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

8.  Selective bacterial adherence to oral epithelial surfaces and its role as an ecological determinant.

Authors:  R J Gibbons; J van Houte
Journal:  Infect Immun       Date:  1971-04       Impact factor: 3.441

9.  Glucosamine-containing sphingoglycolipids from sheep erythrocytes.

Authors:  M Momoi; T Yamakawa
Journal:  J Biochem       Date:  1978-08       Impact factor: 3.387

10.  Glycolipid receptors for uropathogenic Escherichia coli on human erythrocytes and uroepithelial cells.

Authors:  H Leffler; C Svanborg-Edén
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

View more
  86 in total

1.  Inhibition of pneumococcal adherence to human nasopharyngeal epithelial cells by anti-PsaA antibodies.

Authors:  Sandra Romero-Steiner; Tamar Pilishvili; Jacquelyn S Sampson; Scott E Johnson; Annie Stinson; George M Carlone; Edwin W Ades
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

2.  Pneumococcal 6-phosphogluconate-dehydrogenase, a putative adhesin, induces protective immune response in mice.

Authors:  D Daniely; M Portnoi; M Shagan; A Porgador; N Givon-Lavi; E Ling; R Dagan; Y Mizrachi Nebenzahl
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

3.  Pneumococcal interactions with epithelial cells are crucial for optimal biofilm formation and colonization in vitro and in vivo.

Authors:  Laura R Marks; G Iyer Parameswaran; Anders P Hakansson
Journal:  Infect Immun       Date:  2012-05-29       Impact factor: 3.441

4.  Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model.

Authors:  H H Tong; L E Blue; M A James; T F DeMaria
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

5.  Serine protease PrtA from Streptococcus pneumoniae plays a role in the killing of S. pneumoniae by apolactoferrin.

Authors:  Shaper Mirza; Landon Wilson; William H Benjamin; Jan Novak; Stephen Barnes; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

6.  Influenza A virus alters pneumococcal nasal colonization and middle ear infection independently of phase variation.

Authors:  John T Wren; Lance K Blevins; Bing Pang; Lauren B King; Antonia C Perez; Kyle A Murrah; Jennifer L Reimche; Martha A Alexander-Miller; W Edward Swords
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

7.  Streptococcus pneumoniae produces at least two distinct enzymes with neuraminidase activity: cloning and expression of a second neuraminidase gene in Escherichia coli.

Authors:  M Camara; T J Mitchell; P W Andrew; G J Boulnois
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

8.  The NanA neuraminidase of Streptococcus pneumoniae is involved in biofilm formation.

Authors:  Dane Parker; Grace Soong; Paul Planet; Jonathan Brower; Adam J Ratner; Alice Prince
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

9.  Defence of mucous membranes by antibodies, receptor analogues and non-specific host factors.

Authors:  L A Hanson; B Andersson; B Carlsson; U Dahlgren; L Mellander; O Porras; T Söderström; C Svanborg Edén
Journal:  Infection       Date:  1985       Impact factor: 3.553

10.  Apoptosis induced by a human milk protein.

Authors:  A Håkansson; B Zhivotovsky; S Orrenius; H Sabharwal; C Svanborg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.